SG
SCMP

Societe Generale’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Societe Generale’s Portfolio SCMP Stock Details SCMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		$442K Buy
+40,316
New +$451K ﹤0.01% 1765

Other funds holding SCMP

KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
TA
Teachers Advisors New York $81.7B AUM 13.62% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Societe Generale's SCMP Position: Q2 2016 in Review

Societe Generale opened a new position in Sucampo Pharmaceuticals, Inc. (SCMP) in Q2 2016: 40,316 shares worth $442K. The stake represents ﹤0.01% of the portfolio and ranks #1765 among its holdings.

136 funds tracked by Wall St. Rank hold SCMP as of Q2 2016.

  • Societe Generale held 40,316 shares of Sucampo Pharmaceuticals, Inc. worth $442K as of Q2 2016.
  • Sucampo Pharmaceuticals, Inc. was a new Societe Generale position in Q2 2016.
  • Sucampo Pharmaceuticals, Inc. made up ﹤0.01% of Societe Generale's portfolio in Q2 2016, its #1765 holding.
  • 136 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q2 2016.

Based on Societe Generale's 13F filing for Q2 2016, filed 2 Aug 2016.